Document is current
Any future updates will be listed below
-
Authors
Cardona, Christopher L.
Wei, Lai
Kim, Joonwon
Angeles, Ellen
Singh, Gunjandeep
Chen, Shiye
Patel, Ronak
Ifediora, Nkechime
Canoll, Peter
Teich, Andrew F.
Hargus, Gunnar
Chavez, Alejandro
Sproul, Andrew A.
-
Funding
Funding for this research was provided by:
National Institute on Aging (R01AG073360)
National Institute on Aging (R01AG073360)
National Institute on Aging (P30AG066462-02)
National Institute on Aging (P30AG066462-02)
National Institute on Aging (P30AG066462-02)
Burroughs Wellcome Fund
National Institutes of Health (DP2NS131566-02)
Henry and Marilyn Taub Foundation
Thompson Family Foundation (TAME-AD)
- License Information
-
More Information
Article History
Received: 29 April 2025
Accepted: 16 September 2025
First Online: 3 December 2025
Declarations
:
: The hiPSC line FA0000010 (FA10) is a commercially available and deidentified line from RUCDR and is exempt from considerations of human subject research.
: A.C., J.K., and L.W. have patents related to CRISPR-based tools and their application that are managed by Harvard and Columbia University.
